Auto Injectors Market Projected Growth By 2027

1
Auto Injectors Market, 2021 - 2027
Copyright Precision Business Insights
2
Market Overview
The worldwide auto-injectors market is primarily
driven by the rising prevalence and occurrences
of anaphylaxis and food allergies around the
world. Advances in autoinjector technology are
allowing patients, particularly first-time users,
to self-inject medicines with fewer errors and
less anxiety. These devices minimize or eliminate
needle connections, removing a significant
barrier to adhere for some patients. In
addition, the report discusses the implications
of COVID-19, including the industry's initial
response and strategies for ensuring business
continuity in the coming years. View Detailed
Report Description
3
Market Segments
The global auto injectors market has been
fragmented based on 1. By Type Fillable,
Prefilled2. By Technology Automated,
Manual3. By Application Anaphylaxis,
Rheumatoid Arthritis, Multiple Sclerosis,
Others4. By Geography North America, Asia
Pacific, Europe, Middle East and Africa, Latin
America Request Sample Report
4
Key Players
Some of the major key players in the auto
injectors market areBecton, Dickinson and
Company (U.S), Sanofi (France), Pfizer, Inc.
(U.S.), Mylan N.V. (U.S.), Novartis AG
(Switzerland), Bayer AG (Switzerland) , Johnson
and Johnson Services Inc., Antares Pharma, Inc.
(U.S.), Amgen Inc. (U.S.) and Eli Lilly and
Company (U.S). Request Sample Report
5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, 202, RVS Sree Homes, Opp Bharat
Petroleum Pump,Khanamet Road, Hitech City,
Hyderabad, India 500084 Email sales_at_precisionbu
sinessinsights.com Toll Free 1-866-598-1553